Race should be taken into account when making anti-thrombotic drugs, but will drug companies deem it worth researching drugs that are specific to a minority population? As a result, the factors that contribute to the reduced chance of black people to survive heart attacks are essentially social. Also, are microRNA's linked with sickle-cell anemia, another disease that is common in black people? Until drugs and other treatments become more tailored to minority groups, it is best that one do research and take preventative measures to hopefully reduce the likely-hood of developing whatever illness to which one might be predisposed.
Friday, November 22, 2013
Genetic difference in blood clotting may underlie racial health disparity
Labels:
anti-thrombotic,
microRNA,
race
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment